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Derivation of human embryonic stem cell lines from single
cells of 4-cell stage embryos: be aware of the risks
Sir,
Most of the human embryonic stem cell (hESC) lines have
been derived from the inner mass of blastocyst stage
embryos, some from 8-cell stage morula (Streclchenko et al.,
2004) and some from isolated blastomeres from morulae
(Chung et al., 2008).
In a very recent abstract, a Belgian team (Van de Velde
et al., 2008) elegantly established an embryonic stem cell
line from a single blastomere isolated from a 4-cell
stage embryo (from 1 out of 12 embryos). This team had
a unique opportunity to establish good quality embryos
from donated oocytes and sperm. By deriving a line
from one blastomere, they gave evidence for the totipotency
of single cells at 4-cell stage in human embryo. The result-
ing hESC line was, however, chromosomally abnormal
with a deletion in chromosome 18 and a duplication in
chromosome 7.
In Switzerland, the embryo research law is very strict, and
obtaining good quality embryos for hESC derivation is vir-
tually impossible, even though the law allows hESC deri-
vation and culture. Our team recently derived a hESC line
(Ch-ES1) from a frozen-thawed 4-cell stage embryo, in
which only one blastomere survived thawing. The surviving
cell grew on human foreskin feeders (Hovatta et al., 2003)
and formed a hESC-like colony which has since then been
passaged and cultured as a hESC line for over a year (Feki
et al., 2008). This line proved to be chromosomally very
abnormal, with triploidies and several deletions and dupli-
cations. It forms malignant teratocarcinoma-like tumors
when injected into SCID mice.
The Belgian team has now an excellent opportunity to show
how often such lines are abnormal, a type of study still very dif-
ficult in many other countries. It is not new that poor quality
embryos often have chromosomal abnormalities (Hardarson
et al., 2003), but on the other hand, we do not know yet how
much culture conditions affect the chromosomes of early
lines, even though culture adaptation is well known (Draper
et al., 2004).
In this light, the interpretation of many media that deri-
vation of lines from single blastomeres is ethically a more
acceptable method of derivation of hESC lines than destroy-
ing whole embryos cannot be supported by the scientific com-
munity. It appears that sometimes even the scientists
themselves provoke such ideas (Chung et al., 2008). The
Belgian team has just been revealing very important biologi-
cal mechanisms, but some media changed even their message
to that direction. Also in Switzerland, we have to make clear
that we now have an important tool to solve some problems in
cancer development, but it does not offer solutions for any
ethical questions in hECS derivation. The fact that hESC
lines can be obtained from cells without destroying the
embryo, or from cells of a ‘dead’ embryo, does not make
such lines ethically more acceptable. Abnormality issues
should not be underestimated.
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Impact of hyperglycemia on early embryo development
and embryopathy: in vitro experiments
using a mouse model
Sir,
Fraser et al. (2007) identify the media they used in their work
as mKSOM and KSOM, and characterize them as a ‘synthetic
oviductal medium enriched with potassium’. We wish to point
out that his characterization is erroneous. A medium called
SOM was developed by Lawitts and Biggers (1991) using the
experimental strategy called ‘sequential simplex optimization’
(hence SOM). SOM medium was not designed to imitate the
composition of oviductal secretions. It was developed to
overcome the 2-cell block which, at the time, interfered with
many studies on the developmental biology of the mouse
embryo. KSOM was later modified by raising the potassium
concentration in SOM (Lawitts and Biggers, 1993) based on
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